LILIAM PALACIOS: Open Payments
NPI 1851843593 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 57 payments from 18 companies in 2025. Trend: 2023 $848 · 2024 $998 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $229 |
| AstraZeneca Pharmaceuticals LP | 8 | $153 |
| ABBVIE INC. | 7 | $152 |
| Lilly USA, LLC | 6 | $91 |
| PFIZER INC. | 4 | $85 |
| Novo Nordisk Inc | 3 | $56 |
| Abbott Laboratories | 3 | $54 |
| Exact Sciences Corporation | 3 | $53 |
| Saluda Medical Americas, Inc. | 2 | $49 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
Products named: REPATHA, UBRELVY, FARXIGA, MOUNJARO, ELIQUIS, OTEZLA, LINZESS, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
